Abstract
Radiotherapy (RT) is commonly used as adjuvant treatment following hysterectomy and double oophorectomy in endometrial carcinoma. Prophylactic vaginal brachytherapy (BT) is the most common treatment in BT units. The PORTEC and GOG 99 studies have attempted to clarify the indications of BT and postoperative external RT, changing treatment standards. However, prophylactic BT regimens are very varied and there is currently no consensus on how to treat patients in terms of dose per fraction and number of fractions. Moreover, unoperated cases of endometrium are uncommon and there is limited experience in their treatment with BT. The 9th Consensus Meeting of the SEOR and SEFM Brachytherapy Group, held in Malaga on 11 March 2011, was therefore dedicated to “Brachytherapy in Endometrial Carcinoma”. This article presents the consensus on treatment of endometrial carcinoma in operated (prophylactic vaginal BT) and unoperated (endouterine BT) patients.
Similar content being viewed by others
References
González E, Lobato R (2008) Cáncer de endometrio operado. BT con HDR, cilindro vaginal. In: Guinot JL, Lanzós E, Muñoz V et al (eds) Guía de Braquiterapia. SEOR and Nucletron, Madrid
Creutzberg CL, van Putten WLJ, Koper PCM et al; PORTEC Study Group (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. Lancet 355:1404–1411
Scholten AN, van Putten WL, Beerman H et al (2005) Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63:834–838
Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751
Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an openlabel, non-inferiority, randomized trial. Lancet 375:816–823
Eltabbakh GH, Piver MS, Hempling RE, Shin KH (1997) Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 38:373–380
Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC et al (2004) Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 22:1234–1241
Nag S, Erickson B, Parikh S et al (2000) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 48:779–790
Small W Jr, Erickson B, Kwakwa F (2005) American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys 63:1502–1507
Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer 60:2035–2041
ASTEC/EN.5 Study Group (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373:137–146
Johnson N, Cornes P (2007) Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG 114:1313–1320
Lee CM, Szabo A, Shrieve DC et al (2006) Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295:389–397
Kong A, Johnson N, Cornes P et al (2007) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev (2):CD003916
Fanning J (2001) Long-term survival in intermediate risk endometrial cancer (stage IG3, IC, II) treated with fully lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82:371–374
Nag TY, Niclin JL, Perrin LC et al (2001) Postoperative vaginal vault brachytherapy for node negative stage II (occult) endometrial carcinoma. Gynecol Oncol 81:193–195
Mutch DG (2009) The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol 115:325–328
Pera J, Gutiérrez C, Polo A (2008) Cáncer de endometrio operado. BT con LDR. In: Guinot JL, Lanzós E, Muñoz V et al (eds) Guía de Braquiterapia. SEOR and Nucletron, Madrid
Martinez-Monge R, Nagore G, Cambeiro M et al (2007) Intravaginal 1-week high-dose-rate brachytherapy alone for stages I-II endometrial cancer. Brachytherapy 6:195–200
Rovirosa A, Ascaso C, Sánchez-Reyes A et al (2011) Three or four fractions of 4–5 Gy per week in postoperative high dose rate brachytherapy for endometrial carcinoma. Int J Radiat Oncol Biol Phys 81:418–423
Guinot JL, Pérez-Calatayud J, Rodríguez S et al (2010) Consensus on 3D treatment planning in gynaecologic brachytherapy of the Radiation Oncology Spanish Society (SEOR) Brachytherapy Group. Clin Transl Oncol 12:181–187
Rovirosa A, Biete A (2008) Cáncer de endometrio no operado. BT con LDR. In: Guinot JL, Lanzós E, Muñoz V et al (eds) Guía de Braquiterapia. SEOR and Nucletron, Madrid
Pinar B, Martín de Vidales MC (2008) Cáncer de endometrio no operado. BT con HDR. In: Guinot JL, Lanzós E, Muñoz V et al (eds) Guía de Braquiterapia. SEOR and Nucletron, Madrid
Author information
Authors and Affiliations
Corresponding author
Additional information
on behalf of the SEOR and the SEFM Brachytherapy Groups
Rights and permissions
About this article
Cite this article
Guinot, J.L., Pérez-Calatayud, J., Azcoaga, J.M. et al. Consensus on treatment of endometrium carcinoma with brachytherapy. Clin Transl Oncol 14, 263–270 (2012). https://doi.org/10.1007/s12094-012-0794-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0794-2